These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28418032)

  • 21. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
    Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
    Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC
    J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
    Yang B; Guo M; Herman JG; Clark DP
    Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide DNA methylation profiles in hepatocellular carcinoma.
    Shen J; Wang S; Zhang YJ; Kappil M; Wu HC; Kibriya MG; Wang Q; Jasmine F; Ahsan H; Lee PH; Yu MW; Chen CJ; Santella RM
    Hepatology; 2012 Jun; 55(6):1799-808. PubMed ID: 22234943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of genes and pathways, including the CXCL2 axis, altered by DNA methylation in hepatocellular carcinoma.
    Subat S; Mogushi K; Yasen M; Kohda T; Ishikawa Y; Tanaka H
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):675-684. PubMed ID: 30564899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma.
    Tao R; Li J; Xin J; Wu J; Guo J; Zhang L; Jiang L; Zhang W; Yang Z; Li L
    PLoS One; 2011; 6(5):e19862. PubMed ID: 21625442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.
    Zhang YJ; Wu HC; Shen J; Ahsan H; Tsai WY; Yang HI; Wang LY; Chen SY; Chen CJ; Santella RM
    Clin Cancer Res; 2007 Apr; 13(8):2378-84. PubMed ID: 17438096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
    Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
    Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
    Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z; Zhang M; Bi J; Xu F; Hu S; Wen J
    Am J Clin Pathol; 2006 May; 125(5):740-6. PubMed ID: 16707376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
    J Pathol; 2014 Aug; 233(4):392-401. PubMed ID: 24838394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation and environmental exposures in human hepatocellular carcinoma.
    Shen L; Ahuja N; Shen Y; Habib NA; Toyota M; Rashid A; Issa JP
    J Natl Cancer Inst; 2002 May; 94(10):755-61. PubMed ID: 12011226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
    Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
    Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
    Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH
    Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma.
    Lee HG; Kim H; Son T; Jeong Y; Kim SU; Dong SM; Park YN; Lee JD; Lee JM; Park JH
    Oncotarget; 2016 Jul; 7(27):41798-41810. PubMed ID: 27260001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide DNA methylation analysis in hepatocellular carcinoma.
    Yamada N; Yasui K; Dohi O; Gen Y; Tomie A; Kitaichi T; Iwai N; Mitsuyoshi H; Sumida Y; Moriguchi M; Yamaguchi K; Nishikawa T; Umemura A; Naito Y; Tanaka S; Arii S; Itoh Y
    Oncol Rep; 2016 Apr; 35(4):2228-36. PubMed ID: 26883180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.